WASHINGTON, July 28 -- Office of the Secretary has issued a rule called: TRICARE Coverage of Clinical Trials and Termination of Expanded Access Treatments.
The rule was published in the Federal Register on July 28 by Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense.
Summary: The Assistant Secretary of Defense for Health Affairs (ASD(HA)) issues this final rule regarding circumstances under which services and supplies related to emerging treatments may be covered under the TRICARE program. This rule finalizes provisions published in two interim final rules (IFRs) with request for comment, which temporarily added coverage for the treatment use of investigational drugs under U.S. Food and Drug Administra...